Sequelae of microsporidial keratoconjunctivitis and its management

Amrita Mohanty1, Sanchita Mitra2, Aparajita Mallick2

  • 1Cornea and Anterior Segment Services, Mithu Tulsi Chanrai Campus, L.V. Prasad Eye Institute, Bhubaneswar, Odisha, India.

Abstract

Insights

Microsporidia keratoconjunctivitis (MKC) can lead to persistent or recurrent eye disease. Topical tacrolimus ointment shows promise in managing subepithelial infiltrates and preventing recurrence, acting as a corticosteroid-sparing agent.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Microbiology

Background:

  • Microsporidia keratoconjunctivitis (MKC) can present with persistent or recurrent ocular inflammation.
  • Understanding the sequelae and effective management strategies for MKC is crucial for visual recovery.

Purpose of the Study:

  • To characterize the long-term consequences (sequelae) of microsporidia keratoconjunctivitis.
  • To outline and evaluate management approaches for persistent and recurrent MKC.

Main Methods:

  • Retrospective analysis of microbiologically confirmed MKC cases with persistent disease from January 2015 to December 2019.
  • Evaluation of patient demographics, clinical presentations, treatment interventions, and outcomes.

Main Results:

  • Sixteen patients (21 eyes) experienced persistent MKC, with common presentations including superficial punctate keratitis (SPK) and subepithelial infiltrates (SEI).
  • Recurrences were observed in eight eyes, with topical corticosteroids and tacrolimus ointment being common treatments.
  • Visual recovery was significant in persistent cases, but not in recurrent cases, with some eyes developing residual scarring.

Conclusions:

  • Sequelae of MKC are relatively common and can impact visual outcomes.
  • Topical 0.03% tacrolimus ointment appears effective for treating SEIs and preventing recurrence, serving as a valuable corticosteroid-sparing option.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
215
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
908
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.0K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
782
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
52
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
94